Long-term Prognosis of Patients With Hepatitis B Related Acute-on-chronic Liver Failure
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorThird Affiliated Hospital, Sun Yat-Sen University
About this trial
This study is to investigate the long-term outcomes and prognostic risk factors in patients recovered from hepatitis B virus related acute on-chronic liver failure.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age from 18 to 65 years old;
The diagnosis consistent with hepatitis b associated chronic acute liver failure；
After hospitalization, the survival time > 90 days；
The inpatient clinical data are complete.
Disqualifiers
Human immunodeficiency virus infection or congenital immune deficiency diseases;
Liver cancer and other tumors, autoimmune liver disease, genetic and metabolic liver disease, or other serious diseases that significantly affect patient survival;
Other conditions that the researchers judged not appropriate for inclusion.
Trial population
This study population were patients with hepatitis b-related acute on-chronic liver failure in the department of infectious diseases, the third affiliated hospital of sun yat-sen university.
Trial design
Design model
Other
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
300 Participants
are grouped into 1 trial groupGroup A: HBV-ACLF
Trial outcomes
Primary outcomes
1
adverse events
Adverse events included decompensated cirrhosis, hepatocellular carcinoma, liver transplantation, and death.
Time frame
5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov